Adams Respiratory Sues Perrigo Over Mucinex Patent

Law360, New York (September 27, 2007, 12:00 AM EDT) -- Adams Respiratory Therapeutics Inc. on Thursday filed suit against Perrigo Co., claiming the generic maker’s abbreviated new drug application for a generic version of Mucinex infringes its patent for the drug.

Adams filed a complaint in the U.S. District Court for the District of New Jersey after Perrigo informed the company that it had submitted an ANDA to the U.S. Food and Drug Administration. The ANDA seeks approval to manufacture and sell 600 mg extended-release single-ingredient guaifenesin, the generic equivalent of Adams’ Mucinex SE.

Perrigo’s ANDA...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.